The new Eurosurveillance website is almost here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Further content
Skip Navigation LinksEurosurveillance Editorial policy
Editorial policy
Scope of the journal To the topTo top

Eurosurveillance aims to be the authoritative and representative public health voice of the communicable disease community in Europe and beyond. Our main focus is on Europe, and authors from other parts of the world are encouraged to submit articles, provided that they add value to a European audience.

Our main objectives are to:

  • provide facts and guidance for health professionals and decision-makers to facilitate the implementation of effective prevention and control measures;
  • support the preparedness and response to health threats in Europe through the rapid dissemination of high-quality authoritative scientific information on relevant outbreaks or emergency situations;
  • provide a European-specific platform for health professionals to share scientific findings in infectious disease epidemiology, prevention and control;
  • disseminate surveillance data on communicable diseases and publish analyses and interpretations of these data;
  • offer, where possible, assistance to authors from all European Union Member States in improving the impact and quality of national information on communicable diseases.

All articles in Eurosurveillance are indexed by PubMed/MEDLINE, Scopus, EMBASE and EBSCO and undergo a rigorous peer review by independent reviewers to guarantee unbiased selection based on scientific quality.
The Eurosurveillance way To the topTo top

We are a small enthusiastic editorial team and enjoy the unbureaucratic contact with our authors and reviewers from whom we often receive positive feedback. We provide a high level of editorial support and see it as a service to our readers and authors to ensure that each published article is as correct and readable as possible within the constraints of time. In the majority of cases, we do not finally accept a manuscript before editing is complete, because the editing process itself may bring up points that have gone unnoticed before.

Details of our evaluation and peer review process are described in our For authors pages
Target readership To the topTo top

Eurosurveillance is primarily aimed at all those concerned with communicable disease epidemiology, prevention and control in Europe and beyond. In addition to public health professionals and decision-makers at all levels, medical practitioners, microbiologists and scientists in the field of communicable diseases and members of the relevant health organisations, the journal may also be of interest to professionals from other related fields such as pharmacists, behavioural scientists and scientific journalists.
Topics and contents To the topTo top

We publish preliminary outbreak reports and alerts in the form of rapid communications, as well as in-depth analyses of outbreaks and epidemiological disease patterns based on surveillance data, and scientific studies. We also cover practices, policies and guidance regarding communicable disease prevention and control, major developments in the field of diagnostics, immunisation, drug resistance and therapy, and summaries of reports from national institutions/organisations. Letters to the editor provide a platform for exchange of information. On occasion we also publish short news pieces on current public health developments.

Most articles in Eurosurveillance concern infectious disease events and trends in Europe, but we also report events from other parts of the world, particularly regarding emerging communicable diseases of particular importance to the European region.

In specific circumstances, Eurosurveillance may cover other potential threats to the health of European citizens.

More information on the article categories and formats can be found in the For authors section.

Languages To the topTo top

Eurosurveillance is published in English. In the Archives , some full articles and abstracts published before 2008 are also available in French, Spanish, Italian and Portuguese.
Ethical issues To the topTo top

The ECDC grants editorial freedom to the editorial team of Eurosurveillance ( The views expressed in the journal are those of the authors and may not necessarily comply with views and policy of ECDC.

Eurosurveillance follows guidelines on editorial independence produced by the World Association of Medical Editors (see Relationship between Editors and Owners) and the Code of Conduct produced by the Committee on Publication Ethics.

Since January 2010, Eurosurveillance has been accredited by the Health on the Net (HON) Foundation as adhering to the HON code of conduct (HONcode). HON is a non-governmental, non-profit organisation with the purpose of supporting users to identify sound, reliable and trustworthy health information on the Internet.

Eurosurveillance follows the International Committee of Medical Journal Editors(ICMJE) Uniform Requirements for Manuscripts Submitted to Biomedical Journals .

Information collected, such as the email addresses of our subscribers, will be stored only for the purposes of processing of the manuscript and will never be used for commercial (or advertising) purposes or passed on to any third party, unless required by law.

Our data protection notice can be found here (Data protection notice).

Appeals and complaints To the topTo top

Eurosurveillance has a procedure for handling appeals and complaints. All appeals and complaints should be sent the editorial office (

For appeals against our decision on a manuscript, we involve two Associate editors, who assess the appeal. Under exceptional circumstances, an editorial advisor with relevant expertise may be involved.

Allegations related to research integrity, such as double publication, theft or misuse of data, or disputed authorship, are dealt with by the Editor-in-chief in accordance with COPE flowcharts and guidelines (, involving the relevant persons or institutions as needed.

Complaints about the length of time taken in processing a manuscript, our behaviour, etc. are dealt with by the editorial team. Final evaluation – if escalation to a higher authority for individual instances is necessary – is made by the Editor-in-chief, who will provide an annual report about major complaints to the Associate editors and the publisher.
Changes in authorship To the topTo top

Eurosurveillance has a policy for changes in authorship i.e. adding or removing authors. This policy reflects the stage of the publication process at which such changes are made/requested.

Adding authors after submission before publication of the article
In cases where during the processing of a manuscript, after submission and before publication of an article, editors notice an additional author’s name on the author list or if the corresponding author requests addition of a new author, the editorial team will ask the corresponding author to send an email to in which they explain why the author should be added, state that the new author fulfils ICMJE authorship criteria and describe their detailed contributions; all co-authors should be in Cc of this email to ensure that they are informed ahead of publication.

Adding authors after publication of the article
In cases where the corresponding author requests the addition of a new author within a reasonable time after publication of the article, we proceed as above. In addition, co-authors should be asked by the corresponding author to actively confirm their consent to the author being added, in an email to
Once confirmation has been obtained and consensus has been reached, changes will be made online and an author correction will be published in the next Eurosurveillance issue. In case of differing opinions we will follow the approach suggested in respective COPE flowcharts.

Removing authors after submission before publication of the article
In cases where editors notice an author’s name has been removed or if the corresponding author requests an author to be removed before publication, the Editor-in-chief will evaluate the request and explanation why they should be removed. The author concerned should be informed about the request by the editorial team or the corresponding author and should actively agree to be removed from the author list in an email to All co-authors should be in Cc of the email exchange to ensure that they are informed.

Removing authors after publication of the article
In cases where an author requests to be removed from article after its publication, the Editor-in-chief will evaluate the request and explanation why they wish to be removed. Hereafter, the editorial team informs the corresponding author about the request and asks for active consent by them and all co-authors in individual emails to with the requesting author and all co-authors in copy.
Once consent has been obtained by all parties for removing the author, changes will be made online and an author correction will be published in the next Eurosurveillance issue. In case of differing opinions we will follow approach suggested in respective COPE flowcharts.
Copyright issues To the topTo top

Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. The Author retains ownership of the copyright for their manuscript, but allows anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the Author and source are cited in accordance with the detailed information provided in the licence.
After publication, we encourage authors to deposit final articles in repositories such as PubMedCentral.
When submitting an article, authors are requested to send a signed agreement with authors for each article, signed by the corresponding author on behalf of all authors. It should be scanned and sent to the Eurosurveillance office as part of the submission process using our online submission system.

We, as many other journals and institutions, use a tool (iThenticate) to routinely check incoming submissions for overlap with published material. We then make a case-by-case decision on whether the similarities represent a reason for us not to accept the paper for publication. If we identify overlap of an extent that we consider critical, we inform the authors of this and attach the similarity report, which in our opinion is a useful tool that can help the authors to improve their manuscript. We emphasise here that this measure does not imply that the material was not correctly acknowledged and that it should not be mistaken for an accusation of fraud. However, even if cited correctly, verbatim copies of full sentences or paragraphs from published material can constitute a breach of copyright, for which we as a journal can be held responsible. Our policy follows the opinion of the committee on publication ethics (COPE).
Indexation in PubMed/MEDLINE To the topTo top

Long articles (before 2008 Eurosurveillance monthly release) have been indexed by MEDLINE since January 2001, while rapid communications (before 2008 Eurosurveillance weekly release) have been indexed by MEDLINE since January 2005. The Index Medicus abbreviation for Eurosurveillance is Euro Surveill.
How to cite Eurosurveillance articles To the topTo top

Eurosurveillance articles should be cited as indicated at the top of the web version of the articles, using the electronic page number. Although part of the online content appears in print, the page numbers in print compilations and pdf files should not be cited. Correct citations with electronic page numbers can be found at the top of each article on the website and also in the pdf and the print versions.

An example of a correct citation is:
Scheutz F, Møller Nielsen E, Frimodt-Møller J, Boisen N, Morabito S, Tozzoli R, Nataro JP, Caprioli A. Characteristics of the enteroaggregative Shiga toxin/verotoxin-producing Escherichia coli O104:H4 strain causing the outbreak of haemolytic uraemic syndrome in Germany, May to June 2011. Euro Surveill. 2011;16(24):pii=19889.
Become a reviewer To the topTo top

If you think you could help us to peer-review articles, please register on our online submission system and provide as much detail as possible about your areas of expertise.
Contacting the editorial team To the topTo top

If you have any questions about Eurosurveillance, please contact our editorial team at
ISSN numbers To the topTo top

The online and print formats of Eurosurveillance are assigned separate ISSNs.
Online content: ISSN 1560-7917
Print compilation: ISSN 1025-496X

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.